A WHO/Europe and ECDC analysis finds high antibiotic resistance in serious hospital infections. In 21 of 43 countries reporting 2025 Klebsiella pneumoniae data, at least half the samples resisted third-generation cephalosporins. For Acinetobacter, at least half the samples resisted carbapenems in 21 of 38 reporting countries. These are laboratory findings from blood and cerebrospinal fluid, not the proportion of all patients whose treatment failed.

Why it matters

The findings point to pressure on hospital treatment options and the importance of laboratory testing, infection prevention and careful antibiotic use.

What the evidence cannot tell us

  • Testing practices differ between countries and can overrepresent the sickest patients.
  • The denominators cover countries reporting each bacterium–antibiotic combination, not every country in the region.

Read the sources. Credit the work.

The reporting and documents behind this brief, linked directly to the source. Verified publisher and author credits appear where available; other entries show their actual website address. Several links may draw on the same underlying reporting or research.

  1. who.int

    WHO/Europe: resistance to key antibiotics in hospital bacteria (opens in a new tab)

    who.int · November 18, 2026

    Primary document / sourceContent read for this publication · November 20, 2026

This story was written and checked using AI against the linked evidence. No routine human review is claimed. Read the method.

Suggest an update or correction
Published corrections